These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38971782)

  • 1. Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022.
    Ilmavirta H; Ollgren J; Räisänen K; Kinnunen T; Hakanen AJ; Rantakokko-Jalava K; Jalava J; Lyytikäinen O
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):72. PubMed ID: 38971782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing proportions of extended-spectrum β-lactamase-producing isolates among
    Ilmavirta H; Ollgren J; Räisänen K; Kinnunen T; Hakanen AJ; Jalava J; Lyytikäinen O
    Euro Surveill; 2023 Oct; 28(43):. PubMed ID: 37883040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
    Marković T; Jeinić L; Smitran A; Petković M
    Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.
    Lemenand O; Coeffic T; Thibaut S; Colomb Cotinat M; Caillon J; Birgand G;
    J Infect; 2021 Dec; 83(6):664-670. PubMed ID: 34600019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.
    Chung HC; Lai CH; Lin JN; Huang CK; Liang SH; Chen WF; Shih YC; Lin HH; Wang JL
    Antimicrob Agents Chemother; 2012 Feb; 56(2):618-22. PubMed ID: 22123694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli İsolates.
    Çetinkol Y; Sandalli C; Çalgin MK; Yildirim AA; Akyildiz E; Karaman E; Çiçek AÇ
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):131-141. PubMed ID: 28420242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
    de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM
    Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamase-producing
    Romyasamit C; Sornsenee P; Kawila S; Saengsuwan P
    Microbiol Spectr; 2024 Jul; 12(7):e0021324. PubMed ID: 38809095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
    Khanfar HS; Bindayna KM; Senok AC; Botta GA
    J Infect Dev Ctries; 2009 May; 3(4):295-9. PubMed ID: 19759493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
    Bonkat G; Müller G; Braissant O; Frei R; Tschudin-Suter S; Rieken M; Wyler S; Gasser TC; Bachmann A; Widmer AF
    World J Urol; 2013 Dec; 31(6):1427-32. PubMed ID: 23358791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013.
    Martin D; Fougnot S; Grobost F; Thibaut-Jovelin S; Ballereau F; Gueudet T; de Mouy D; Robert J;
    J Infect; 2016 Feb; 72(2):201-6. PubMed ID: 26702736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populations.
    Tsai WL; Hung CH; Chen HA; Wang JL; Huang IF; Chiou YH; Chen YS; Lee SS; Hung WY; Cheng MF
    J Microbiol Immunol Infect; 2018 Dec; 51(6):723-731. PubMed ID: 28927684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
    Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI
    Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.